Business · 20/02/20261 min read
FDA Withdraws Approval of 11 Abbreviated New Drug Applications
The FDA is withdrawing approval of 11 abbreviated new drug applications from multiple applicants, following notification that the drug products were no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →